399 Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than high dose chemotherapy (HDCT) with peripheral stem cell transplantation (PSCT)?

2003 ◽  
Vol 1 (5) ◽  
pp. S122
Author(s):  
P. Kellokumpu-Lehtinen
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
Cost Effectiveness ◽  
High Risk ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Peripheral Stem Cell Transplantation ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer

scholarly journals High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

2003 ◽  
Vol 349 (1) ◽  
pp. 7-16 ◽  
Author(s):  
Sjoerd Rodenhuis ◽  
Marijke Bontenbal ◽  
Louk V.A.M. Beex ◽  
John Wagstaff ◽  
Dick J. Richel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
High Risk ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Hematopoietic Stem ◽  
Stem Cell Rescue ◽  
High Risk Breast Cancer ◽  
High Risk Breast ◽  
Risk Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document